Clinical Trial

The Osteoarticular Manifestations in Patients With Gitelman Syndrome

Study acronym: CPPD and more
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 10, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT06922370
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Gitelman Syndrome, CPPD - Calcium Pyrophosphate Deposition Disease
Enrollment 120 participants
Start Date 2021-11-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-10